Latest Breaking News On - Ventyx biosciences inc - Page 1 : comparemela.com
05.06.2024 - VTX3232 demonstrated improvements in body weight, systemic inflammatory biomarkers and cardiometabolic parameters in diet-induced obesity (DIO) mice Additive effects were observed for VTX3232 in combination with the GLP-1 receptor agonist . Seite 1
John-nussNasdaqVentyx-biosciences-incChief-scientific